202 related articles for article (PubMed ID: 18486627)
1. Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.
Hwang SA; Kruzel ML; Actor JK
Biochimie; 2009 Jan; 91(1):76-85. PubMed ID: 18486627
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin modulation of BCG-infected dendritic cell functions.
Hwang SA; Actor JK
Int Immunol; 2009 Oct; 21(10):1185-97. PubMed ID: 19692539
[TBL] [Abstract][Full Text] [Related]
3. Immune Activity of BCG Infected Mouse Macrophages Treated with a Novel Recombinant Mouse Lactoferrin.
O'Shea KM; Hwang SA; Actor JK
Ann Clin Lab Sci; 2015; 45(5):487-94. PubMed ID: 26586698
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin modulation of antigen-presenting-cell response to BCG infection.
Wilk KM; Hwang SA; Actor JK
Postepy Hig Med Dosw (Online); 2007; 61():277-82. PubMed ID: 17507876
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.
Hwang SA; Kruzel ML; Actor JK
Tuberculosis (Edinb); 2016 Dec; 101S():S53-S62. PubMed ID: 27727130
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c).
Hwang SA; Arora R; Kruzel ML; Actor JK
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S49-54. PubMed ID: 20006305
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Wilk KM; Budnicka M; Olsen M; Bangale YA; Hunter RL; Kruzel ML; Actor JK
Vaccine; 2007 Sep; 25(37-38):6730-43. PubMed ID: 17698261
[TBL] [Abstract][Full Text] [Related]
8. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Kruzel ML; Actor JK
Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
[TBL] [Abstract][Full Text] [Related]
10. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice.
Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H
Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.
Hwang SA; Wilk KM; Bangale YA; Kruzel ML; Actor JK
Med Microbiol Immunol; 2007 Sep; 196(3):171-80. PubMed ID: 17377816
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages.
Soualhine H; Deghmane AE; Sun J; Mak K; Talal A; Av-Gay Y; Hmama Z
J Immunol; 2007 Oct; 179(8):5137-45. PubMed ID: 17911599
[TBL] [Abstract][Full Text] [Related]
13. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells.
Demangel C; Bean AG; Martin E; Feng CG; Kamath AT; Britton WJ
Eur J Immunol; 1999 Jun; 29(6):1972-9. PubMed ID: 10382760
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein.
Fulton SA; Reba SM; Pai RK; Pennini M; Torres M; Harding CV; Boom WH
Infect Immun; 2004 Apr; 72(4):2101-10. PubMed ID: 15039332
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.
Hwang SA; Wilk K; Kruzel ML; Actor JK
Vaccine; 2009 May; 27(23):3026-34. PubMed ID: 19428915
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
17. Iron modulates the replication of virulent Mycobacterium bovis in resting and activated bovine and possum macrophages.
Denis M; Buddle BM
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):189-99. PubMed ID: 15993492
[TBL] [Abstract][Full Text] [Related]
18. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer nanocoating of live Bacille-Calmette-Guérin mycobacteria with poly(I:C) and chitosan enhances pro-inflammatory activation and bactericidal capacity in murine macrophages.
Speth MT; Repnik U; Griffiths G
Biomaterials; 2016 Dec; 111():1-12. PubMed ID: 27716523
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
